Home › Agent Hub › Agent Tools › Part D coverage by drug › Aristada
Agent Tools
Aristada is a brand of aripiprazole lauroxil. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 5,028 of 5,492 Medicare Part D and Medicare Advantage drug plans (91.6%) list Aristada on their formulary, across 245 of 286 formularies. The most common placement is tier 5 (4,679 plans, 93.1% of those covering it). 81 of the covering plans require prior authorization (1.6%), 67 step therapy and 3,988 a quantity limit. Generic aripiprazole is on 5,492 of 5,492 plans (100%).
43 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 43 of them $0; 4,985 charge coinsurance instead — median 26% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 5,059 of 5,496 plans covered it (92%); 2027: 5,028 of 5,492 (91.6%).
Of 4,367 plans offered in both years, 6 added it to the formulary and 68 dropped it.
Among plans covering it both years, 37 moved it to a higher tier and 25 to a lower one; 11 added prior authorization and 36 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 113 |
| Tier 2 | 1 |
| Tier 4 | 235 |
| Tier 5 | 4,679 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 242 of 323 | 74.9% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,867 of 3,200 | 89.6% | 1.2% |
| Special needs plans (SNP) | 1,919 of 1,969 | 97.5% | 2.4% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 5 | 0 |
| UnitedHealthcare | 830 of 830 | Tier 5 | 0 |
| Devoted Health | 728 of 728 | Tier 5 | 0 |
| Aetna Medicare | 631 of 631 | Tier 5 | 0 |
| Wellcare | 234 of 268 | Tier 5 | 0 |
| HealthSpring | 186 of 226 | Tier 5 | 0 |
| Kaiser Permanente | 112 of 112 | Tier 5 | 0 |
| SCAN Health Plan | 83 of 83 | Tier 4 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 77 of 77 | Tier 5 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 5 | 0 |
| Wellpoint | 63 of 63 | Tier 5 | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 5 | 0 |
| Zing Health | 36 of 36 | Tier 5 | 0 |
| Capital Blue Cross | 8 of 35 | Tier 5 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 5 | 0 |
| Medica | 1 of 27 | Tier 5 | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 5 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 5 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 110 of 114 | 96.5% |
| Alaska | 7 of 9 | 77.8% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 145 of 147 | 98.6% |
| Arkansas | 83 of 85 | 97.6% |
| California | 373 of 397 | 94% |
| Colorado | 104 of 106 | 98.1% |
| Connecticut | 52 of 54 | 96.3% |
| Delaware | 38 of 43 | 88.4% |
| District of Columbia | 12 of 12 | 100% |
| Florida | 503 of 545 | 92.3% |
| Georgia | 147 of 149 | 98.7% |
| Guam | 1 of 1 | 100% |
| Hawaii | 48 of 50 | 96% |
| Idaho | 40 of 45 | 88.9% |
| Illinois | 129 of 132 | 97.7% |
| Indiana | 136 of 138 | 98.6% |
| Iowa | 61 of 64 | 95.3% |
| Kansas | 81 of 84 | 96.4% |
| Kentucky | 119 of 121 | 98.3% |
| Louisiana | 123 of 125 | 98.4% |
| Maine | 50 of 52 | 96.2% |
| Maryland | 47 of 49 | 95.9% |
| Massachusetts | 87 of 89 | 97.8% |
| Michigan | 128 of 182 | 70.3% |
| Minnesota | 38 of 63 | 60.3% |
| Mississippi | 102 of 104 | 98.1% |
| Missouri | 168 of 170 | 98.8% |
| Montana | 24 of 27 | 88.9% |
| Nebraska | 43 of 51 | 84.3% |
| Nevada | 98 of 100 | 98% |
| New Hampshire | 23 of 25 | 92% |
| New Jersey | 68 of 73 | 93.2% |
| New Mexico | 65 of 68 | 95.6% |
| New York | 187 of 215 | 87% |
| North Carolina | 174 of 176 | 98.9% |
| North Dakota | 17 of 26 | 65.4% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 149 of 171 | 87.1% |
| Oklahoma | 78 of 81 | 96.3% |
| Oregon | 90 of 92 | 97.8% |
| Pennsylvania | 192 of 323 | 59.4% |
| Puerto Rico | 25 of 64 | 39.1% |
| Rhode Island | 22 of 29 | 75.9% |
| South Carolina | 87 of 89 | 97.8% |
| South Dakota | 19 of 30 | 63.3% |
| Tennessee | 153 of 156 | 98.1% |
| Texas | 404 of 407 | 99.3% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 51 of 53 | 96.2% |
| Vermont | 12 of 14 | 85.7% |
| Virginia | 142 of 144 | 98.6% |
| Washington | 110 of 114 | 96.5% |
| West Virginia | 59 of 69 | 85.5% |
| Wisconsin | 90 of 96 | 93.8% |
| Wyoming | 10 of 13 | 76.9% |
Medicare Part D paid for 107,050 30-day fills of Aristada in 2024 for about 13,087 enrollees, at an average total cost of $2,417.87 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Aristada and the rest of a client's list on every plan in their county.
Estimate Aristada costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.